Abstract:Migraine has been known to afflict humankind since antiquity as an intense pulsatile painful neurological entity [<a href="#B1">1</a>,<a href="#B2">2</a>]. Migraine headache is currently the third most common disease with an estimated global prevalence of 15%, and, is also ranked among the top ten debilitating diseases imparting substantial suffering to the family in addition to the sufferer, being the fourth most burdensome disease in women according to the 2012 Global Burden of Disease study that, in desperation, propels medication abuse, yet by general consensus its etiology remains uncertain [<a href="#B3%20B4%20B5">3–5</a>]. Management of both episodic and chronic migraine has a massive escalating fiscal impact in developed countries, as the poorly understood frequently refractory noncommunicable disorder(s) with a typical but only partially defined genetic component [<a href="#B5%20B6%20B7%20B8%20B9">5–9</a>] continues to challenge current human problem-solving capacity despite impressive technological advances. Increasingly frequent multicenter often industry-specific bottom-line driven randomized clinical trials (RCTs) in the face of incomplete scientific logic or commonsense add data into a profusely confused perspective [<a href="#B10%20B11%20B12">10–12</a>]. Without a salient and robust pathophysiologic matrix, all therapies advocated at the tertiary-care level are empirical cart-before-the-horse strategies poorly translated at the level of the general population, leading to research frustration [<a href="#B12">12</a>]. Precisely for the same reason, migraine has the broadest possible spectrum of potential therapies, both pharmacological and nonpharmacological, including surgery. Although, by wide consensus, migraine is regarded as a primary brain disorder [<a href="#B3%20B4%20B5%20B6%20B7%20B8%20B9">3–9</a>,<a href="#B13%20B14%20B15">13–15</a>], disruption of the blood–brain barrier (BBB) during attacks has not been established [<a href="#B13">13</a>], and, first-line hydrophilic preventive drugs that clearly influence the primary pathogenetic processes(es) or 'afferent limb' of migraine aura-headache such as atenolol and nadolol [<a href="#B16%20B17%20B18%20B19">16–19</a>] do not freely cross BBB or influence occipital- or brainstem neuronal function [<a href="#B10">10</a>]. Application of nitroglycerin ointment to skin of fronto-temporal region precipitates headache in migraineurs without involving the CNS [<a href="#B20">20</a>]. This unacknowledged pharmacologic–clinical disconnect is being steadily widened by logic-challenging RCTs and meta-analyses, both being commonly used to sustain assumptive but intrinsically weak pathogenetic theories and therapies through mathematic extrapolations.While there has been an exponential accumulation of data, opinion and reviews in migraine (and other primary headache) literature, pathophysiologic certitude has proven elusive. Experiment, statistical sophistication and extreme nosologic 'splitting' has left reflection and logic far behind data in evolution of migraine as a discipline, while observation – never itself completely objective – has no scaffolding to be arranged into a meaningful matrix. Interpretation of the biologic significance of a large, fragmented, disconnected, burgeoning but disparate and often controversial body of data encompassing recorded peripheral and central changes in the laboratory including neuroimaging remains unresolved [<a href="#B10%20B11%20B12">10–12</a>]. Biology of migraine is not synonymous with 'laboratory' or 'nonenvironmental' but is the elucidation of the concatenation of physiologic forces that push or pull the migraine patient towards either the aura/headache phase or the aura/headache-free state [<a href="#B11">11</a>]. While perceived psychophysical stress as well as occurrence of reactive oxygen species stress is both ubiquitous and nonspecific, migraine affects approximately only up to a fifth of humankind, with an apparently inexhaustible adaptive cranial/brain intrinsic noradrenergic-serotonergic-vasopressinergic mechanism keeping the majority of the human cohort free from the disorder [<a href="#B11">11</a>,<a href="#B21">21</a>]. Conversely, despite a nebulous clinical and scientific landscape, some researchers believe that understanding of migraine pathophysiology is advancing rapidly [<a href="#B14">14</a>,<a href="#B15">15</a>]. Supporting evidence for such enthusiastic belief for an imminent breakthrough, is, however, conspicuously absent.The chance discovery of cortical spreading depression (CSD) in experimental animals by Leão (1944) [<a href="#B22">22</a>], the presumed cortical origin of personal experience of scintillating scotomata (SS) without headache attacks by Lashley (1941) [<a href="#B23">23</a>] and the assumed linkage between these two sets of cross-species events by Milner (1958) [<a href="#B24">24</a>], set stage for a prolonged philo<p>-Abstract Truncated-</p>

Our evolving understanding of migraine with aura

Exploring the multifaceted characteristics of aura in migraine: A multicenter, cross-sectional study

Episodic Migraine With and Without Aura: Key Differences and Implications for Pathophysiology, Management, and Assessing Risks

Somatosensory migraine auras evoked by bihemispheric cortical spreading depression events in human parietal cortex

Migraine Visual Aura and Cortical Spreading Depression-Linking Mathematical Models to Empirical Evidence

Multisensory hallucinations and other unusual sensory experiences in the context of migraine: a systematic review

Signatures of Migraine Aura in High-Density-EEG

Functional connectivity changes in complex migraine aura: beyond the visual network

Altered neurovascular coupling in migraine without aura

Pathophysiology of migraine: an increasingly complex narrative to 2020

The complications of migraine with aura

Involvement of gap junction channels in the pathophysiology of migraine with aura

Altered Resting State Functional Activity and Microstructure of the White Matter in Migraine With Aura

Grey matter structure within the visual networks in migraine with aura: multivariate and univariate analyses

Subsegmentation of the hippocampus in subgroups of migraine with aura patients: advanced structural neuroimaging study

Visual migraine aura iconography: A multicentre, cross-sectional study of individuals with migraine with aura

Abnormal effective connectivity in migraine with aura under photic stimulation

Role of cortical spreading depression in the pathophysiology of migraine

Disrupted functional connectivity between sub-regions in the sensorimotor areas and cortex in migraine without aura

In search of a neuropsychological profile for migraine: A scoping review

Reduced neurovascular coupling of the visual network in migraine patients with aura as revealed with arterial spin labeling MRI: is there a demand-supply mismatch behind the scenes?